Related by context. Frequent words. (Click for all words.) 68 imaging neurodegenerative disorders 68 commercial bioproduction 66 activity dependent neuroprotective 66 VEGFR2 inhibitor 65 functional genomics proteomics 64 hepatitis C lupus 64 metastatic colorectal 64 Small interfering RNAs 64 protein ADNP 64 photomedicine 63 R sorafenib tablets 63 NASDAQ CRXL 63 cystic fibrosis inflammation autoimmune 63 malignant infectious 63 Initiates Phase II 63 immunology molecular 63 Romidepsin 63 inflammation autoimmune diseases 63 ® bortezomib 63 Crucell NV NYSE Euronext 63 cardio metabolic disease 62 Antigen Express website 62 transplantation biology 62 inflammatory autoimmune diseases 62 addressing idiopathic pulmonary 62 fibrosis IPF 62 novel RNAi therapeutics 62 www.combinatorx.com 62 By Thomas Gryta 62 Nasdaq ENMD 61 mediate RNAi 61 Inc. Nasdaq SUPG 61 By Neil Osterweil 61 topically delivered 61 Sangamo ZFP technology 61 drug conjugate 61 Potassium Chloride Sodium Ascorbate 61 called lipopeptides 61 R bortezomib 61 oncology infectious diseases 61 autoimmune disorders asthma 61 Sports Editor larry@gaffneyledger.com 61 identify protein biomarkers 61 developing Zerenex TM 60 ZFP Therapeutics 60 Presents Positive 60 By BEVERLY CORBELL 60 optical biosensors 60 PINNACLEDIGEST.COM S PAST PERFORMANCE 60 Antigen Express comprise immunotherapeutics 60 Inc. Nasdaq IMGN 60 perifosine novel potentially 60 promising anticancer 60 multi kinase inhibitor 60 commercializing therapeutic 60 Note SHIPPING CHARGES 60 ARIAD vision 60 NYSE Amex RNN 60 cancer immunotherapeutics 60 gastrointestinal mucositis 60 Staff Writer jschramm@minotdailynews.com 60 SIMULATED TRADING PROGRAMS IN 60 WHICH ARE NOT PURELY 59 Inc. NASDAQ TRGT 59 Nasdaq CRXL 59 phenylketonuria PKU developed 59 By TERRANCE HARRIS 59 Completes Enrollment 59 Daclizumab 59 BY CHRIS McDANIEL 59 gets USFDA nod 59 please visit http:/www.supergen.com 59 Colorado Coagulation Endocrine Sciences 59 * Azixa 59 bio therapeutics 59 www.syntapharma.com 59 markets therapeutic ultrasonic 59 VERIFICATION OF THE 59 By MICHAEL FORTUNA 59 proteasome inhibitor 59 generation antisense 59 BY JOHN ECKBERG 59 Staff Writer larry@gaffneyledger.com 59 www.vical.com 59 Sapacitabine 59 Receives Orphan Drug Designation 59 CrossRef Web 59 NASDAQ SNTA biopharmaceutical 59 BY JIM HAND 58 immunologic diseases 58 REPORTS FILED FROM 58 novel orally administered 58 www.vivus.com 58 BY DAVID LINTON 58 Ladbrokes.tv 58 Paris EURONEXT SAN 58 orally absorbed 58 By THERESA CAMPBELL 58 BioMarin develops 58 COMPANIES FUTURE CAPITAL REQUIREMENTS 58 Sodium Sulfate Sodium Chloride